Clinical Trial

Healthcare Utilization and Costs Among Hospitalized Patients With Cardiomyopathy

Completed
View on ClinicalTrials.gov →
Summary
Cardiomyopathy is the most common inherited cardiovascular disease, showing family aggregation, and it has a huge psychological and economic burden on family members. In this study, the investigators collected clinical information and costs of patients hospitalized with cardiomyopathy and establish a database to characterize real-world cost profile and inform cost management of cardiomyopathy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-23; most recent amendment 2026-05-18.
Status change: Enrolling by Invitation → Completed 2026-05-18
Trial Details
NCT Number NCT06893731
Lead Sponsor China National Center for Cardiovascular Diseases
Conditions Cardiomyopathies, Cost
Enrollment 15,764 participants
Start Date 2017-03-01
Primary Completion 2022-03-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-20